Specialised Therapeutics announces TGA approval of YORVIPATH
Specialised Therapeutics welcomes the registration of YORVIPATH by the Therapeutic Goods Administration, “for the treatment of chronic ...
FIRST AND ONLY TREATMENT FOR CHRONIC HYPOPARATHYROIDISM APPROVED IN AUSTRALIA
Independent biopharmaceutical company Specialised Therapeutics (ST) welcomes the registration of YORVIPATH® ...